Viewing Study NCT02208167


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-01-10 @ 9:41 PM
Study NCT ID: NCT02208167
Status: COMPLETED
Last Update Posted: 2019-10-07
First Post: 2014-07-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Sponsor: University of North Carolina, Chapel Hill
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module